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Abstract
Mechanisms whereby T lymphocytes contribute to synovial inflammation in rheumatoid
arthritis are poorly understood. Here we review data that indicate an important role for cell
contact between synovial T cells, adjacent macrophages and fibroblast-like synoviocytes
(FLS). Thus, T cells activated by cytokines, endothelial transmigration, extracellular matrix or
by auto-antigens can promote cytokine, particularly TNFa, metalloproteinase production by
macrophages and FLS through cell-membrane interactions, mediated at least through
b-integrins and membrane cytokines. Since soluble factors thus induced may in turn
contribute directly to T cell activation, positive feedback loops are likely to be created. These
novel pathways represent exciting potential therapeutic targets.
Keywords: adhesion molecule, cell contact, cytokine, T lymphocyte, rheumatoid arthritis
Received: 17 April 2000
Accepted: 23 May 2000
Published: 18 July 2000
Arthritis Res 2000, 2:374–378
© Current Science Ltd (Print ISSN 1465-9905; Online ISSN 1465-9913)
FLS = fibroblast-like synoviocytes; ICAM-1 = intercellular cell-adhesion molecule-1; IFN = interferon; MMP = matrix metalloproteinase; RA =
rheumatoid arthritis; TCR = T cell receptor; TIMP = tissue inhibitor of MMP; TNF = tumour necrosis factor.
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Introduction
The elucidation of pathways by which T lymphocytes
might contribute to synovial inflammation in rheumatoid
arthritis (RA) has proved elusive. Thus, mechanisms by
which synovial T cells are activated, and subsequently
effect articular inflammation, remain incompletely under-
stood. Moreover, the magnitude and nature of such effec-
tor pathways might not be constant over time or in
different individuals. The predominance of macrophage-
derived cytokines, particularly tumour necrosis factor
(TNF)-a in the hierarchy of synovial inflammation has been
clearly demonstrated in several recent clinical studies [1•].
Those factors that in turn promote such macrophage acti-
vation could represent effective therapeutic targets, but
are currently ill-defined. This brief review will explore the
hypothesis that a significant proportion of such pro-inflam-
matory activity might reside in synovial T cells through their
capacity to modulate inflammation by cell–cell contact.
Potential T cell effector mechanisms in RA
synovial membrane
Data from animal models, recognised HLA associations
and the clinical efficacy of T cell targeted therapies impli-
cate T cells in promoting RA synovitis [2,3]. Empirically,
synovial T cells might drive inflammation through the
release of inflammatory mediators, particularly cytokines, or
through pathways dependent on cell contact. Several
reports indicate that synovial CD4+, CD45RO+ T cells are
predominantly of ‘type 1’ polarity [4–10]. Synovial T cell
clones are usually of Th1 phenotype. Up to 80% of synovialhttp://arthritis-research.com/content/2/5/374
T cells are CCR5+; when stimulated with mitogen they pre-
dominantly express interferon (IFN)-g but not interleukin
(IL)-4, as assessed by ELISPOT or intracellular fluores-
cence-activated cell sorting. T cell derived cytokines that
can be detected in synovium, albeit at low levels, are of
Th1 type and include IFN-g and IL-17. Using double spe-
cific antibodies, we recently detected spontaneous IFN-g
production by less than 1% of RA synovial T cells ex vivo
(JA Gracie and IB McInnes, unpublished data), commensu-
rate with the foregoing immunohistochemical observations.
A priori, therefore, it seems unlikely that such cytokine
output by T cells could fully explain the extensive and per-
petual synovial inflammation apparent in RA.
Evidence for interactions between T cells and
macrophages in synovial membrane
T cells and macrophages lie in juxtaposition within and
adjacent to cellular aggregates in the synovial membrane,
providing for reciprocal cellular cross-talk. Such interac-
tions can effectively activate T cells through the local
release of cytokines (eg IL-12, IL-18), through co-stimula-
tion (eg via pathways dependent on CD28, CD154 or
CD47), and/or through the presentation of putative
auto-antigens [11–13]. However, it has recently become
clear that T cells in turn might be stimulatory to adjacent
macrophages. Dayer and colleagues have provided
elegant results demonstrating that T lymphocytes can
modulate the activity of a variety of cell types through cell
contact [14•,15•]. However, most such studies have
employed mitogen-activated T cells. We recently demon-
strated that freshly isolated, paraformaldehyde-fixed T-lym-
phocyte-enriched populations from synovial fluid might
induce TNF-a production directly by blood or synovial
macrophages through pathways dependent on cell
contact [16•], without additional exogenous stimulation.
Moreover, this property can be sustained or enhanced in
vitro by the addition of cytokines that activate T cells, such
as IL-15 [16•]. These observations indicate that a funda-
mental property of synovial T cells might be the activation
of adjacent cells mediated by cell contact.
Several results now indicate that cytokine-mediated
‘bystander’ activation can confer monocyte activatory
capacity on memory T cells, representing a physiological
‘surrogate’ for mitogen. The cytokine-mediated activation
(by IL-2, IL-1b and TNF-a) of resting human CD45RO+,
CD4+ T cells can promote cytokine production and help
from B cells in the absence of T cell receptor (TCR) liga-
tion [17•]. Similarly, paraformaldehyde-fixed, IL-15-acti-
vated T cells derived from peripheral blood are capable of
inducing TNF-a production by macrophages [16•]. Combi-
nations of T cell activatory cytokines, including TNF-a, IL-6
and IL-15, which are present within inflamed synovial
membrane, seem to be synergistic in this respect [18].
Soluble cytokines present in the local milieu, eg TNF-a,
granulocyte–macrophage colony-stimulating factor, IL-10
and IL-11, will further modulate the magnitude of cognate
interactions. Complex local autocrine regulatory loops
have been proposed in which membrane-bound and
secreted cytokines, together with adhesion molecule inter-
actions, are implicated in defining the ratios of synthesis of
pro-inflammatory and anti-inflammatory cytokines, eg
TNF-a/IL-10 [19] (Fig. 1).
Studies investigating blood-derived lymphocyte–macrophage
interactions clearly indicate that secretory activity arising
from cell contact extends beyond TNF-a to include numer-
ous cytokines such as IL-1b and IL-12, and cytokine
inhibitors such as TNF receptor p75 and IL-1RA [14,20,
21•,22]. We have also recently demonstrated that synovial
Figure 1
Pathways by which T cell interactions can contribute to synovial
inflammation. T cells activated by cytokine combinations, by contact
between extracellular matrix and endothelium and potentially by
autoantigen, can activate the production of cytokines, MMPs and
prostaglandins (PGs) by macrophages and FLS, creating potential
positive feedback loops, and leading in turn to articular damage.
Contact interactions might be variably mediated through adhesion
molecules or membrane cytokines. The parallel secretion of
pro-inflammatory and anti-inflammatory cytokines and cytokine receptors
further modulate responses. The production by FLS of cytokines, such
as IL-7, IL-15 and IL-18, that activate T cells is likely, but because few
studies have yet directly addressed this issue, these pathways have
been omitted. Interactions between synovial T and B lymphocytes are
beyond the scope of this review.Arthritis Research    Vol 2 No 5 McInnes et al
macrophages consistently release low levels of IL-15 after
contact with cytokine-activated synovial or blood-derived
T cells (unpublished data). The production of matrix metal-
loproteinase (MMP), but not of tissue inhibitor of MMP
(TIMP) 1, by THP-1 cells and blood-derived macrophages
might also be induced after contact with T cells [23]. The
relative role of cell contact and soluble factors apparently
vary for the production of different cytokines. During inves-
tigations of the pro-inflammatory activities of T cells and
macrophages in glomerular inflammation, we recently
defined discrete requirements for cell contact and for
soluble factors during the induction of expression of
cytokines, chemokines and adhesion molecules by mesan-
gial or renal tubular epithelial cells [24,25]. For example,
whereas either cell-contact or soluble factors induced
monocyte chemotactic protein-1 (MCP-1) and IP-10,
RANTES production by RTEC was dependent exclusively
on contact. Similar studies are required to characterise
such regulatory diversity within RA synovial membrane.
The precise membrane ligands implicated in interactions
between synovial T cells and macrophages are currently
unclear. Co-incubation with neutralising antibodies against
LFA-1 (lymphocyte function associated antigen-1), intercel-
lular cell-adhesion molecule-1 (ICAM-1) and CD69 effec-
tively suppresses synovial T cell induced activation of
macrophages [15•,16•]. By extension from studies with
T cells derived from peripheral blood, CD11b, CD40L and
CD45 might also be implicated [21•,22]. Membrane-bound
cytokines, particularly IL-1a, TNF-a and IFN-g, clearly repre-
sent logical additional candidate molecules [14•]. It is also
of interest that membrane-bound IL-15 has recently been
described in blood-derived monocytes [26]. However,
such studies are not straightforward because steric hin-
drance by antibodies can confound, and the formal charac-
terisation of critical pathways remains elusive. Similarly, the
signalling consequences within macrophages after T cell
contact have been little studied. These might not be easily
predicted. For example, a recent comparison of TNF-a syn-
thesis induced by LPS and CD45 in monocytes revealed
the discrete use of phosphoinositide 3-kinase and the
nuclear factor NF-kB, but common use of p38
mitogen-activated protein kinase (MAPK) pathways by
these diverse stimuli [27]. Thus, the precise mechanisms
by which T cells are activated, and the relative contribution
of subsequent cell contact in comparison with macrophage
activation mediated by soluble factors, might profoundly
influence signalling events in synovial macrophages. Such
detail will probably have important implications in the
design of future targeted therapies.
The significance of the predominant Th1 polarity of synovial
T cells in the context of cognate interactions is unclear.
Recent studies indicate that cytokine-activated Th1 cells
exhibit greater potential to enhance the expression of
monocyte IL-1b through cell contact than do Th2 cells
[21•]. This might in part be mediated through CD154–
CD40 interactions. In contrast, Th1 and Th2 cells induce
similar IL-10 production, whereas Th2 cells are more effi-
cient in inducing IL-1RA synthesis [22]. We recently
described the expression of IL-18 in RA synovial mem-
brane, which together with IL-12 and IL-15 probably sus-
tains a Th1 phenotype in synovial T cells [11]. In the
absence of high levels of IFN-g production in situ, cognate
interactions involving synovial Th1 cells might be of critical
importance. Studies addressing this important issue are
under way in several laboratories.
Interactions of T cells with synovial fibroblasts
Cell contact between T lymphocytes and fibroblast-like
synoviocytes (FLS) is a further important area of interest.
Early studies demonstrated that cytokine-activated FLS
bind T cells through pathways that are dependent on at
least ICAM-1 [28]. The synthesis of FLS collagen types I
and III is downregulated at the transcriptional level by cell
contact with mitogen-activated T cells or membrane
preparations derived from T cells [29]. These effects are
not tissue-specific because similar effects can be medi-
ated on dermal fibroblasts. Direct contact with blood-
derived activated T cells, or synovial CD4+ and CD8+
T cell clones, induces the production of MMP and
prostaglandin by FLS [30]. In contrast, TIMP1 is only
briefly upregulated in this system. Membrane-bound
cytokines, including TNF-a and IL-1a, but not CD69,
CD154 or CD11b, seem crucial to such interactions
between T cells and FLS [30]. The capacity of FLS to
respond in co-cultures might be enhanced by TGF-b.
Moreover, because FLS activated by IL-1b and TNF-a
express in turn cytokines capable of T cell activation,
including IL-7, IL-15 and IL-18 [11,16•,31], it is likely that
local positive feedback loops, similar to those described
above for T cells and monocytes, might be generated.
Together these results suggest that interactions between
T cells and FLS could contribute significantly to the extra-
cellular matrix dysregulation characteristic of RA.
Which factors activate synovial T cells to
promote cell–cell interactions?
The foregoing discussion has focused on ‘bystander’
cytokine-mediated T cell activation. This provides for
TCR-independent activation, by which polyclonal memory
T cell populations can contribute within an inflammatory
lesion, irrespective of local antigen expression. This
hypothesis does not preclude a role for T cell populations
driven by autoantigens [32]. Several recent reports have
identified oligoclonal T cell expansion in RA synovial mem-
brane, particularly among CD4+, CD28– cells [33],
although molecular targets remain unknown. However,
whether such expanded antigen-specific T cell subsets
can contribute in vivo to chronic inflammation in a quanti-
tatively important manner through cell contact is as yet
unclear.The fundamental importance of T cell activation after inter-
actions with endothelial cells has long been recognised.
CD45RO+ T cells from peripheral blood exhibit intrinsic
migratory potential and are further activated during transmi-
gration through endothelia [34,35]. This can be demon-
strated directly by using the human synovium–SCID
(severe combined immunodeficiency) mouse model in
which human T cell migration is critically dependent on the
expression of adhesion molecules and cytokines on
endothelial cells [36]. This model provides further powerful
evidence of a central role for polyclonal T cells in promoting
synovial inflammation in vivo, because T cell depletion
mediated by anti-CD2 within synovial grafts leads to the
suppression of IL-1b, TNF-a and IL-15 levels and of MMP
expression. The administration of T cells leads in turn to
replenishment of these cytokine activities [37•].
Conclusion
The therapeutic success of TNF-a blockade illustrates the
potential of selective immune pathway targeting in vivo.
The foregoing results strongly suggest that T cells might
promote the production of pro-inflammatory cytokines and
MMP through cell–cell interactions within the synovial
membrane (Fig. 1). It is intriguing that the response after
anti-CD4 treatment is correlated with the proportion of
synovial CD4+ T cells coated by antibody [38]. Moreover,
the mechanism for action of anti-TNF-a antibodies, might
potentially include the targeting of T cells through recogni-
tion of membrane TNF-a. Thus, therapeutic strategies that
target both TNF-a and T cells, or critical pathways depen-
dent on cell contact deserve consideration.
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